Unibio USA ApS

CVR 38179845 · Private limited company (ApS) · Active · Medium risk

Unibio USA ApS is a Private limited company (ApS), founded on , based in Roskilde. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 9 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 25k and a net result of DKK -20k. CEO: Søren Olrik Eklund.

Bankruptcy risk for Unibio USA ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 75% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor resigned in the last yearYes · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38179845
Status
Active
Company type
Private limited company (ApS)
Founded
(9 years)
Address
Langebjerg 1
4000 Roskilde
Municipality
Roskilde
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 50k
Auditor
Cedra Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 9
Missing annual reportNo
Negative equityNo
Equity ratio27.8%
Current ratio139%
Moves (last 2 years)0
CEO changes in total5
CEO's previous bankruptcies0
Other companies at the address50
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Net profitDKK -20kDKK -26kDKK -17k
EquityDKK 25kDKK 45kDKK 71k
Total assetsDKK 90kDKK 62kDKK 86k
CashDKK 89kDKK 62k–
Short-term debtDKK 65kDKK 17k–
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025181
1 Jan 2024 – 31 Dec 2024169
1 Jan 2023 – 31 Dec 2023172
1 Jan 2022 – 31 Dec 2022103
1 Jan 2021 – 31 Dec 2021158
1 Jan 2020 – 31 Dec 2020153
1 Jan 2019 – 31 Dec 2019143
1 Jan 2018 – 31 Dec 2018141
14 Nov 2016 – 31 Dec 201771

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSøren Olrik EklundCurrent
CEOLeif Jacobsen
CEOJesper Halling Pedersen
CEOJakob Brix Christensen
Owner (100%)UNIBIO A/SCurrent
AuditorCedra Godkendt RevisionsaktieselskabCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderUNIBIO A/SCurrent

The CEOs' other companies

Søren Olrik Eklund – 1 other companies

Leif Jacobsen – 2 other companies

Jakob Brix Christensen – 10 other companies

Address history (3 moves)

Langebjerg 1, 4000 Roskilde
Langebjerg 1, 4000 Roskilde
Niels Bohrs Allé 17, 5230 Odense M
Billedskærervej 8, 5230 Odense M

Other companies at the same address

Similar companies in Roskilde

Questions and answers about Unibio USA ApS

Has Unibio USA ApS gone bankrupt?

No, Unibio USA ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Unibio USA ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of Unibio USA ApS?

Søren Olrik Eklund is the CEO of Unibio USA ApS.

Who is the auditor of Unibio USA ApS?

Unibio USA ApS most recently used Cedra Godkendt Revisionsaktieselskab.

When was Unibio USA ApS founded?

Unibio USA ApS was founded on 14 November 2016.

What is the equity of Unibio USA ApS?

Equity was DKK 25k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.